Just about a week after signing a controversial contract with the UK’s national health service, Palantir Technologies Inc. launched an influencer marketing campaign to counter criticism of the patient data platform it’s building, potentially breaching terms of the deal.

After winning the bid on Nov. 21, Palantir contracted with a digital marketing agency to solicit interest from content personalities. “I’m getting in touch regarding one of our current campaigns,” the marketers wrote in emails to influencers, according to copies of communications obtained by the legal nonprofit Good Law Project and shared with Bloomberg. The pitch said the objective was “to clear up misinformation relating to some recent data privacy concerns that were shared in the UK press.”